Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model
This study provides a comprehensive framework for understanding sorafenib resistance in HCC, alongside a validated prognostic model that holds potential for clinical application.
Authors
- Kuan He
- Zhou Fang (ORCID: https://orcid.org/0000-0002-5231-6539)
- Jun Li (ORCID: https://orcid.org/0000-0002-8664-4813)
- Kai Liu (ORCID: https://orcid.org/0000-0001-7034-7235)
- Xi Zhao (ORCID: https://orcid.org/0000-0002-9002-203X)
- Hongyan Hui
Institutions
- Songshan Lake Materials Laboratory (CN)
- First Affiliated Hospital of Xinxiang Medical University (CN)
- Dongguan People’s Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-08-20
- DOI
- https://doi.org/10.1007/s12672-025-03442-x
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00